Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Brain drugs can now cross the once impenetrable blood–brain barrier

Conceptual collage illustration showing a representation of the blood-brain barrier .

Illustration: Jasiek Krzysztofiak; photographs: Zephyr/SPL; Steve Gschmeissner/SPL; Living Art Enterprises/SPL

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 641, 1086-1088 (2025)

doi: https://doi.org/10.1038/d41586-025-01569-z

Updates & Corrections

  • Correction 04 June 2025: An earlier version of this story mistakenly stated that cells direct therapeutic IDS to the lysosome as waste. Rather, they usually send the transferrin receptor to the lysosome for processing, which brings therapeutic IDS to where it is needed. The story also referred to an adeno-associated virus as a type of adenovirus. These are distinct classes of virus.

References

  1. Khoury, N. et al. Nature Commun. 16, 1822 (2025).

    Article  PubMed  Google Scholar 

  2. Barker, S. J. et al. Sci. Transl. Med. https://doi.org/10.1126/scitranslmed.adi2245 (2024).

    Article  Google Scholar 

  3. Huang, Q. et al. Science 384, 1220–1227 (2024).

    Article  PubMed  Google Scholar 

  4. Liang, X. et al. Nature Commun. 16, 4028 (2025).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links